PPI Market Snapshot: Kapidex Joins The Party Fashionably Late

Undeterred by a crammed proton pump inhibitor market already filled with established brand drugs, low-cost generics and over-the-counter alternatives, Takeda is moving ahead with the launch of a new PPI, Kapidex (dexlansoprazole)

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet